Your browser doesn't support javascript.
loading
Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial-mesenchymal transition in clear-cell renal cell carcinoma.
Yang, Ruo-Nan; Zhou, Fu-Rong; Wang, Hong-Yang; Wang, Qing-Hai; Ji, Jian-Lei; Huang, Tao; Guo, Chen; Dong, Zhen; Cao, Yan-Wei.
Afiliação
  • Yang RN; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Zhou FR; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
  • Wang HY; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Wang QH; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Ji JL; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Huang T; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Guo C; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Dong Z; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
  • Cao YW; Department of Renal Transplantation and Urology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, China.
Open Life Sci ; 17(1): 1579-1590, 2022.
Article em En | MEDLINE | ID: mdl-36518886

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Open Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Open Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China